2026. HemoTypeSCTM Point-of-care Testing as a Screening Tool for Sickle Cell Disease among Newborns in Ilesa, Nigeria. NIGERIAN JOURNAL OF PAEDIATRICS. 53, 1 (May 2026), 20–27. DOI:https://doi.org/10.63270/njp.v53i1.2000045.